RxDoctor Payments Data

Natalie Bessom

Family Medicine · Dalton, GANPI 1235517137

Payments from drug & device makers

$3,753in general payments, 2019–2025

Across 208 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$743
  • Pfizer$340
  • Lilly USA, LLC$331
  • Novo Nordisk$252
  • Takeda Pharmaceuticals U.S.A., Inc.$243
  • GSK$148
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$3,753100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,753 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$114,476
Medicare patients
342
Services billed
2,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KeveyisDichlorphenamide11$251,360
TrulicityDulaglutide83$97,631
MounjaroTirzepatide69$76,356
EliquisApixaban96$70,517
OzempicSemaglutide67$66,934
RybelsusSemaglutide34$58,338
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$51,098
JardianceEmpagliflozin37$48,646
FarxigaDapagliflozin Propanediol29$23,874
RexultiBrexpiprazole13$21,754
XareltoRivaroxaban17$19,233
LinzessLinaclotide19$12,916
Tresiba Flextouch U-200Insulin Degludec20$11,860
TrintellixVortioxetine Hydrobromide24$11,305
SymbicortBudesonide/Formoterol Fumarate46$11,002

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Xeris Pharmaceuticals, Inc.Keveyis$90$251,36011 claims
Lilly USA, LLCTrulicity, Mounjaro$331$173,987152 claims
Novo NordiskOzempic, Rybelsus$252$125,272101 claims
PfizerEliquis$340$70,51796 claims
GSKTrelegy Ellipta, Breo Ellipta$148$55,98773 claims
Boehringer IngelheimJardiance$59$48,64637 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$120$43,10286 claims
Otsuka America Pharmaceutical, Inc.Rexulti$139$21,75413 claims
Johnson & JohnsonXarelto$114$19,23317 claims
AbbVieLinzess, Synthroid$743$16,70469 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$243$11,30524 claims
Astellas Pharma US IncMyrbetriq$98$7,55311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Dalton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →